Best Cancer Pharma stock in India 2024 to keep an eye on!
Trade Brains
SEPTEMBER 15, 2024
Financially, Beta Drugs saw strong growth with revenue rising from ₹227 crore in 2023 to ₹296 crore in 2024. Its net profit also increased from ₹31 crore in 2023 to ₹36 crore in 2024, reflecting its expanding market presence. Beta Drugs is also focusing on enhancing its sales to 450+ crores by 2026. Price to Earnings Ratio 29.43
Let's personalize your content